Cargando…
Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype
BACKGROUND: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922962/ https://www.ncbi.nlm.nih.gov/pubmed/24495560 http://dx.doi.org/10.1186/1475-2840-13-34 |
_version_ | 1782303539642499072 |
---|---|
author | Vinagre, Irene Sánchez-Quesada, José Luis Sánchez-Hernández, Juan Santos, David Ordoñez-Llanos, Jordi De Leiva, Alberto Pérez, Antonio |
author_facet | Vinagre, Irene Sánchez-Quesada, José Luis Sánchez-Hernández, Juan Santos, David Ordoñez-Llanos, Jordi De Leiva, Alberto Pérez, Antonio |
author_sort | Vinagre, Irene |
collection | PubMed |
description | BACKGROUND: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic control in subjects with T2D and poor glycemic control. METHODS: A cross-sectional study was performed comparing 122 subjects with T2D (59 ± 11 years old, body mass index 30.2 ± 5.6 kg/m2) with 54 control subjects. Patients with T2D were classified according to their LDL subfraction phenotype and inflammatory biomarkers (C-reactive protein, Interleukin-6, Interleukin-8, Transforming growth factor β(1), Monocyte chemotactic protein 1, Leptin, Adiponectin) were evaluated according to the degree of glycemic control, LDL phenotype and other clinical characteristics. Forty-two subjects with T2D were studied before and after 3 months of improving glycemic control by different strategies. RESULTS: Patients with T2D had higher C-reactive protein (CRP) and monocyte chemotactic protein-1 (MCP1) levels and lower adiponectin concentration, compared to controls. T2D subjects with body mass index ≥ 30 kg/m2 had higher CRP levels (5.2 ± 4.8 mg/l vs 3.7 ± 4.3 mg/l; p < 0.05). The presence of LDL phenotype B was related to higher levels of transforming growth factor-β(1) (TGF-β(1)) (53.92 ± 52.82 ng/l vs 31.35 ± 33.74 ng/l; p < 0.05) and lower levels of adiponectin (3663 ± 3044 ng/l vs 2723 ± 1776 ng/l; p < 0.05). The reduction of HbA1c from 9.5 ± 1.8% at baseline to 7.4 ± 0.8% was associated with a significant reduction of TGF-β(1) (41.86 ± 32.84 ng/l vs 26.64 ± 26.91 ng/l; p = 0.02). CONCLUSIONS: Subjects with T2D, especially those with LDL phenotype B and obesity, have higher levels of inflammatory biomarkers. Improvement of glycemic control reduces TGF-β(1) levels, which may contribute partly to its renoprotective role. |
format | Online Article Text |
id | pubmed-3922962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39229622014-05-10 Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype Vinagre, Irene Sánchez-Quesada, José Luis Sánchez-Hernández, Juan Santos, David Ordoñez-Llanos, Jordi De Leiva, Alberto Pérez, Antonio Cardiovasc Diabetol Original Investigation BACKGROUND: Type 2 diabetes mellitus (T2D) is associated with higher cardiovascular risk partly related to an increase in inflammatory parameters. The aim of this study was to determine the association of inflammatory biomarkers with low-density lipoprotein (LDL) subfraction phenotype and glycemic control in subjects with T2D and poor glycemic control. METHODS: A cross-sectional study was performed comparing 122 subjects with T2D (59 ± 11 years old, body mass index 30.2 ± 5.6 kg/m2) with 54 control subjects. Patients with T2D were classified according to their LDL subfraction phenotype and inflammatory biomarkers (C-reactive protein, Interleukin-6, Interleukin-8, Transforming growth factor β(1), Monocyte chemotactic protein 1, Leptin, Adiponectin) were evaluated according to the degree of glycemic control, LDL phenotype and other clinical characteristics. Forty-two subjects with T2D were studied before and after 3 months of improving glycemic control by different strategies. RESULTS: Patients with T2D had higher C-reactive protein (CRP) and monocyte chemotactic protein-1 (MCP1) levels and lower adiponectin concentration, compared to controls. T2D subjects with body mass index ≥ 30 kg/m2 had higher CRP levels (5.2 ± 4.8 mg/l vs 3.7 ± 4.3 mg/l; p < 0.05). The presence of LDL phenotype B was related to higher levels of transforming growth factor-β(1) (TGF-β(1)) (53.92 ± 52.82 ng/l vs 31.35 ± 33.74 ng/l; p < 0.05) and lower levels of adiponectin (3663 ± 3044 ng/l vs 2723 ± 1776 ng/l; p < 0.05). The reduction of HbA1c from 9.5 ± 1.8% at baseline to 7.4 ± 0.8% was associated with a significant reduction of TGF-β(1) (41.86 ± 32.84 ng/l vs 26.64 ± 26.91 ng/l; p = 0.02). CONCLUSIONS: Subjects with T2D, especially those with LDL phenotype B and obesity, have higher levels of inflammatory biomarkers. Improvement of glycemic control reduces TGF-β(1) levels, which may contribute partly to its renoprotective role. BioMed Central 2014-02-04 /pmc/articles/PMC3922962/ /pubmed/24495560 http://dx.doi.org/10.1186/1475-2840-13-34 Text en Copyright © 2014 Vinagre et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Vinagre, Irene Sánchez-Quesada, José Luis Sánchez-Hernández, Juan Santos, David Ordoñez-Llanos, Jordi De Leiva, Alberto Pérez, Antonio Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title | Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title_full | Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title_fullStr | Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title_full_unstemmed | Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title_short | Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
title_sort | inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of ldl subfraction phenotype |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922962/ https://www.ncbi.nlm.nih.gov/pubmed/24495560 http://dx.doi.org/10.1186/1475-2840-13-34 |
work_keys_str_mv | AT vinagreirene inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT sanchezquesadajoseluis inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT sanchezhernandezjuan inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT santosdavid inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT ordonezllanosjordi inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT deleivaalberto inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype AT perezantonio inflammatorybiomarkersintype2diabeticpatientseffectofglycemiccontrolandimpactofldlsubfractionphenotype |